Does LOMITAPIDE Cause Disease progression? 59 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Disease progression have been filed in association with LOMITAPIDE (Juxtapid). This represents 1.6% of all adverse event reports for LOMITAPIDE.
59
Reports of Disease progression with LOMITAPIDE
1.6%
of all LOMITAPIDE reports
56
Deaths
15
Hospitalizations
How Dangerous Is Disease progression From LOMITAPIDE?
Of the 59 reports, 56 (94.9%) resulted in death, 15 (25.4%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Therapy cessation (828)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Off label use (206)
Fatigue (200)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which LOMITAPIDE Alternatives Have Lower Disease progression Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR